» Articles » PMID: 35318298

Production of Inflammatory Mediators in Conditioned Medium of Adipose Tissue-Derived Mesenchymal Stem Cells (ATMSC)-Treated Fresh Frozen Plasma

Abstract

BACKGROUND Inflammation is the body's first response to an illness that causes irritation or infection. Inflammation is tightly correlated with aging, which is a progressive degenerative process. Conditioned medium (CM) from adipose tissue-derived mesenchymal stem cells (CM-ATMSCs) has been shown to stimulate collagen synthesis and dermal fibroblast migration, as well as reduce wrinkles and improve wound healing. This study aimed to observe the production of inflammatory modulators - interleukin (IL)-1alpha, IL-6, IL-10, and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) - in CM-ATMSCs treated with fresh frozen plasma (FFP) at passages 3 (P3), 7, 11, and 15. MATERIAL AND METHODS ATMSCs P3 were obtained from liposuction of female donors, and the CM from ATMSCs was collected. Measurement of these cytokines was performed with ELISA. RESULTS At many passages, IL-6, a proinflammatory modulator, was discovered to be the most powerful modulator among FFP- and non-FFP-treated cells. However, CM-ATMSCs treated with FFP and in the late passage have significant differences (P<0.05) compared to non-FFP treatments and in other passages in their effects on secretion of inflammatory modulators. CONCLUSIONS In conclusion, CM-ATMSC has the potential to secrete proinflammatory modulators.

Citing Articles

Potential antiaging activity of secretome gel of human Wharton's jelly mesenchymal stem cells (hWJ-MSCs) in UV-induced mice models.

Widowati W, Faried A, Adam A, Rahmat D, Widya Kusuma H, Dewi N Iran J Basic Med Sci. 2024; 27(7):868-878.

PMID: 38800010 PMC: 11127088. DOI: 10.22038/IJBMS.2024.70825.15385.


A Response to Article "Hypoxia Effects in Intervertebral Disc-Derived Stem Cells and Discus Secretomes: An in vitro Study" [Letter].

Rinendyaputri R, Noviantari A, Lienggonegoro L Stem Cells Cloning. 2022; 15:63-64.

PMID: 36300159 PMC: 9590353. DOI: 10.2147/SCCAA.S391016.

References
1.
Amani H, Shahbazi M, DAmico C, Fontana F, Abbaszadeh S, Santos H . Microneedles for painless transdermal immunotherapeutic applications. J Control Release. 2020; 330:185-217. DOI: 10.1016/j.jconrel.2020.12.019. View

2.
Choi S, Lee J, Wang K, Phi J, Song S, Song J . Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas. Eur J Cancer. 2011; 48(1):129-37. DOI: 10.1016/j.ejca.2011.04.033. View

3.
Ho C, Lan C, Liao C, Hung S, Li H, Sung Y . Mesenchymal stem cells and their conditioned medium can enhance the repair of uterine defects in a rat model. J Chin Med Assoc. 2017; 81(3):268-276. DOI: 10.1016/j.jcma.2017.03.013. View

4.
Gordon S . The macrophage: past, present and future. Eur J Immunol. 2007; 37 Suppl 1:S9-17. DOI: 10.1002/eji.200737638. View

5.
Al-Sharabi N, Mustafa M, Ueda M, Xue Y, Mustafa K, Fristad I . Conditioned medium from human bone marrow stromal cells attenuates initial inflammatory reactions in dental pulp tissue. Dent Traumatol. 2016; 33(1):19-26. DOI: 10.1111/edt.12277. View